Spago Nanomedical AB (7UX) Stock Statistics & Valuation Metrics

Spago Nanomedical AB has a market cap or net worth of €6.81M. The enterprise value is €35.78M.

Spago Nanomedical AB has 348,196,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Spago Nanomedical AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Spago Nanomedical AB is -2.10. Spago Nanomedical AB’s PEG ratio is 0.04.

In the last 12 months, Spago Nanomedical AB had revenue of 1.91M and earned -32.51M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -34.67M and capital expenditures 0.00, giving a free cash flow of -34.67M billion.

Spago Nanomedical AB pays an annual dividend of ―, resulting in a dividend yield of ―

Spago Nanomedical AB upcoming earnings date is May 7, 2025, TBA Not Confirmed.

Spago Nanomedical AB as a current ratio of 6.58, with Debt / Equity ratio of 0.00%

In the past 12 months, Spago Nanomedical AB has paid 0.00 in taxes.

Spago Nanomedical AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Spago Nanomedical AB has €32.47M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€32.47M billion.

Gross margin is -807.95%, with operating margin of -1764.15%, and net profit margin of -1701.15%.

The average price target for Spago Nanomedical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―